Nykode Therapeutics ASA — Director's Dealing 2021

Dec 3, 2021

1	Details of the person discharging managerial responsibilities
a)	Name	Agnete Brunsvik Fredriksen
b)	Position	Chief Innovation & Strategy Officer
2	Reason for notification
a)	Initial notification/ Amendment	Initial
3	Details of issuer
a)	Name	Vaccibody AS
b)	LEI	254900UKQHWYZJD22017
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Warrants in Vaccibody AS (ISIN: NO0010714785)
b)	Nature of the transaction	Termination of warrants
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		0	1,422,900
d)	Aggregated information	Price	NOK 0
	-Average price,	Volume	1,422,900
	aggregated volume and total amount	Total amount	NOK 0
e)	Date of the transaction	03.12.2021
f)	Place of the transaction	Outside of trading venue

1	Details of the person discharging managerial responsibilities
a)	Name	Agnete Brunsvik Fredriksen
b)	Position	Chief Innovation & Strategy Officer
2	Reason for notification
a)	Initial notification/ Amendment	Initial
3	Details of issuer
a)	Name	Vaccibody AS
b)	LEI	254900UKQHWYZJD22017
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Warrants in Vaccibody AS (ISIN: NO0010714785)
b)	Nature of the transaction	Subscription of warrants
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		0	1,422,900
d)	Aggregated information	Price	NOK 0
	-Average price,	Volume	1,422,900
	aggregated volume and total amount	Total amount	NOK 0
e)	Date of the transaction	03.12.2021
f)	Place of the transaction	Outside of trading venue

1	Details of the person discharging managerial responsibilities
a)	Name	Anders Tuv
b)	Position	Chairman of the Board
2	Reason for notification
a)	Initial notification/ Amendment	Initial
3	Details of issuer
a)	Name	Vaccibody AS
b)	LEI	254900UKQHWYZJD22017
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Warrants in Vaccibody AS (ISIN: NO0010714785)
b)	Nature of the transaction	Termination of warrants
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		0	800,000
d)	Aggregated information	Price	NOK 0
	-Average price,	Volume	800,000
	aggregated volume and total amount	Total amount	NOK 0
e)	Date of the transaction	03.12.2021
f)	Place of the transaction	Outside of trading venue

1	Details of the person discharging managerial responsibilities
a)	Name	Anders Tuv
b)	Position	Chairman of the Board
2	Reason for notification
a)	Initial notification/ Amendment	Initial
3	Details of issuer
a)	Name	Vaccibody AS
b)	LEI	254900UKQHWYZJD22017
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Warrants in Vaccibody AS (ISIN: NO0010714785)
b)	Nature of the transaction	Subscription of warrants
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		0	800,000
d)	Aggregated information	Price	NOK 0
	-Average price,	Volume	800,000
	aggregated volume and total amount	Total amount	NOK 0
e)	Date of the transaction	03.12.2021
f)	Place of the transaction	Outside of trading venue